Omega Healthcare Investors (NYSE:OHI) Updates FY 2024 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 2.840-2.860 for the period, compared to the consensus estimate of 2.830. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on OHI. BMO Capital Markets raised their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research note on Monday, October 7th. Scotiabank raised their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Truist Financial upped their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target for the company in a report on Thursday. Finally, Berenberg Bank began coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They issued a “buy” rating and a $45.00 price target for the company. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, Omega Healthcare Investors currently has an average rating of “Hold” and a consensus price target of $39.70.

Omega Healthcare Investors Price Performance

NYSE OHI traded down $1.27 on Friday, hitting $41.20. 1,901,157 shares of the company’s stock were exchanged, compared to its average volume of 1,648,304. The stock has a 50-day moving average of $40.47 and a 200-day moving average of $35.96. The stock has a market cap of $10.62 billion, a price-to-earnings ratio of 30.28, a P/E/G ratio of 1.37 and a beta of 1.00. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $44.42. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.20). The business had revenue of $252.70 million for the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a return on equity of 9.19% and a net margin of 34.41%. Omega Healthcare Investors’s quarterly revenue was up 17.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.74 earnings per share. Analysts expect that Omega Healthcare Investors will post 2.69 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be paid a dividend of $0.67 per share. The ex-dividend date is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.50%. Omega Healthcare Investors’s payout ratio is presently 197.06%.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by corporate insiders.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.